HOB Biotech Group Corp.,Ltd (SHA:688656)
China
· Delayed Price · Currency is CNY 137.87
-1.23 (-0.88%)
Mar 9, 2026, 3:00 PM CST
SHA:688656 Revenue
In the year 2025, HOB Biotech Group Corp.,Ltd had annual revenue of 398.40M CNY, down -0.98%. HOB Biotech Group Corp.,Ltd had revenue of 106.22M in the quarter ending December 31, 2025, with 11.45% growth.
Revenue
398.40M
Revenue Growth
-0.98%
P/S Ratio
21.69
Revenue / Employee
753.12K
Employees
524
Market Cap
8.64B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 398.40M | -3.94M | -0.98% |
| Dec 31, 2024 | 402.34M | 7.93M | 2.01% |
| Dec 31, 2023 | 394.41M | 74.01M | 23.10% |
| Dec 31, 2022 | 320.39M | 2.68M | 0.84% |
| Dec 31, 2021 | 317.71M | 95.85M | 43.20% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| INKON Life Technology | 1.69B |
| Edan Instruments | 1.90B |
| Guangzhou Wondfo Biotech Co.,Ltd | 2.57B |
| Sino Medical Sciences Technology | 504.11M |
| Shinva Medical Instrument | 9.58B |
| Shenzhen YHLO Biotech | 1.81B |
| Sinocare | 4.71B |
| Qingdao Haier Biomedical Co.,Ltd | 2.33B |